Trailing-twelve-month (TTM) revenue is $211.85 Million with a year-over-year growth of (7.93%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $62,314,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $62,878,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-06 |
| Q1 FY2026Period ended 2026-03-31 | $62,422,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $24,238,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $211,852,000 |
Current P/S: $614,879,507 market capitalization ÷ $211,852,000 TTM revenue = 2.90x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $24.24M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:45:47.959Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Deposit Account | $10M | $11M | $12M | $11M | $11M | $11M |
| Fiduciary and Trust | $9M | $10M | $10M |
$211.85M
$211.85 Million
(7.93%)
vs. $230.10M a year ago (TTM)
+7.45%
5 Year compound annual growth rate
1 Year
(7.93%)
3 Year
+6.61%
5 Year
+7.45%
10 Year
+7.57%
15 Year
+4.93%
20 Year
+4.24%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $242.58M | +$19.51M | +8.75% |
| 2024 | $223.07M | +$31.39M | +16.37% |
| 2023 | $191.68M | +$31.13M | +19.39% |
| 2022 | $160.55M | +$12.63M | +8.54% |
| 2021 | $147.92M | +$3.37M | +2.33% |
| 2020 |
TTM Growth
(7.93%)
3-Year CAGR
+6.61%
5-Year CAGR
+7.45%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $10M |
| $10M |
| $144.55M |
| +$6.24M |
| +4.51% |
| 2019 | $138.31M | +$12.86M | +10.25% |
| 2018 | $125.45M | +$13.15M | +11.71% |
| 2017 | $112.30M | +$7.55M | +7.21% |
| 2016 | $104.75M | +$5.88M | +5.95% |
